Company / R&D per Share
Stoke Therapeutics, Inc. R&D per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.55
FY2025
5-year range
$1.47 / $2.55
FY2021-FY2025
Trend
+42.5%
vs FY2024
Sector context
#81 of 208
Health Care
What the data says
At $2.55, Stoke Therapeutics, Inc.'s r&d per share ranks #81 of 208 in the Health Care sector. R&D per Share has fluctuated over the past 8 years, ranging from $0.96 in FY2020 to $11.80 in FY2018.
Based on SEC 10-K filings.
2.55 in FY2025 with a 5-year CAGR of +21.6%.
Improved from $1.97 to $2.55 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +20.3%
- 5-Year CAGR
- +21.6%
- 10-Year CAGR
- -
Sector benchmark
#81 of 208 in Health CareTop 39% of 208This company $2.55 Sector average $28.82
▼
-91.1% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 42.5% year-over-year.
- Ranks #81 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2018.
- Lowest r&d per share in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.55 | +42.5% |
| FY2024 | $1.79 | -9.3% |
| FY2023 | $1.97 | +34.5% |
| FY2022 | $1.47 | -0.4% |
| FY2021 | $1.47 | +53.4% |
| FY2020 | $0.96 | -27.3% |
| FY2019 | $1.32 | -88.8% |
| FY2018 | $11.80 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026